Sight Sciences Share Price Today
(NASDAQ: SGHT)

Name: Sight Sciences Share Price Today (NASDAQ: SGHT) - Sight Sciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Sight Sciences share price is $2.82 & ₹245.61 as on 5 Feb 2025, 2.30 'hrs' IST

$2.82

▲

0.09

(3.3%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Sight Sciences share price in Dollar and Rupees. Guide to invest in Sight Sciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sight Sciences, along with analyst recommendations, forecasts, and comprehensive financials.

Sight Sciences share price movements

Today's Low: $2.71
Today's High: $2.83
$2.82
4.08%
Downside
Day's Volatility :4.42%
Upside
0.35%
52 Weeks Low: $2.68
52 Weeks High: $8.45
$2.82
5.14%
Downside
52 Weeks Volatility :68.34%
Upside
66.63%

Sight Sciences (SGHT) Returns

Period	Sight Sciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-46.47%	0.5%	0.0%
6 Months	-50.45%	-2.3%	0.0%
1 Year	-37.53%	3.8%	0.0%
3 Years	-82.18%	11.4%	-11.7%

Sight Sciences (SGHT) Key Statistics

in dollars & INR

Previous Close	$2.73
Open	$2.73
Today's High	$2.83
Today's Low	$2.705
Market Capitalization	$141.1M
Today's Volume	$164.7K
52 Week High	$8.45
52 Week Low	$2.675
Revenue TTM	$79.5M
EBITDA	$-49.0M
Earnings Per Share (EPS)	$-1.01
Profit Margin	-63.3%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-45.36%

How to invest in Sight Sciences Stock (SGHT) from India?

It is very easy for Indian residents to invest directly in Sight Sciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sight Sciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sight Sciences or SGHT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sight Sciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sight Sciences shares which would translate to 0.309 fractional shares of Sight Sciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sight Sciences, in just a few clicks!

Returns in Sight Sciences (SGHT) for Indian investors in Rupees

The Sight Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Sight Sciences investment value today

Current value as on today

₹69,396

Returns

₹30,604

(-30.6%)

Returns from Sight Sciences Stock

₹35,469 (-35.47%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Sight Sciences (SGHT)

-83%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Sight Sciences Stock from India on INDmoney has decreased by -83% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sight Sciences

KCK Ltd
8.68%
UBS Group AG
5.02%
BlackRock Inc
4.44%
Bank of America Corp
4.18%
Vanguard Group Inc
3.35%
Jackson Square Partners, LLC
1.82%

Analyst Recommendation on Sight Sciences

Buy

50%Buy

50%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Sight Sciences(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Sight Sciences Stock (SGHT)

What analysts predicted

Upside of 49.65%

Target:

$4.22

Current:

$2.82

Insights on Sight Sciences Stock (Ticker Symbol: SGHT)

Price Movement
In the last 7 days, SGHT stock has moved down by -12.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 21.37M → 20.15M (in $), with an average decrease of 5.7% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -16.26M → -11.06M (in $), with an average increase of 21.7% per quarter
SGHT vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 60.1% return, outperforming this stock by 96.5%
SGHT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 141.0% return, outperforming this stock by 222.3%
Price to Sales
ForSGHT every $1 of sales, investors are willing to pay $1.7, whereas for Boston Scientific Corp., the investors are paying $9.5 for every $1 of sales.

SGHT Sight Sciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$7.5M	-
Net Income	$-14.3M	-
Net Profit Margin	-189.77%	-

	FY19	Y/Y Change
Revenue	$23.3M	↑ 210.07%
Net Income	$-25.9M	↑ 81.03%
Net Profit Margin	-110.8%	↑ 78.97%

	FY20	Y/Y Change
Revenue	$27.6M	↑ 18.38%
Net Income	$-34.7M	↑ 34.11%
Net Profit Margin	-125.52%	↓ 14.72%

	FY21	Y/Y Change
Revenue	$49.0M	↑ 77.12%
Net Income	$-63.0M	↑ 81.48%
Net Profit Margin	-128.61%	↓ 3.09%

	FY22	Y/Y Change
Revenue	$71.3M	↑ 45.7%
Net Income	$-86.2M	↑ 36.98%
Net Profit Margin	-120.9%	↑ 7.71%

	FY23	Y/Y Change
Revenue	$81.1M	↑ 13.63%
Net Income	$-55.5M	↓ 35.59%
Net Profit Margin	-68.53%	↑ 52.37%

	Q2 FY23	Q/Q Change
Revenue	$23.5M	↑ 24.69%
Net Income	$-14.8M	↓ 13.55%
Net Profit Margin	-62.86%	↑ 27.81%

	Q3 FY23	Q/Q Change
Revenue	$20.0M	↓ 14.75%
Net Income	$-13.0M	↓ 11.65%
Net Profit Margin	-65.15%	↓ 2.29%

	Q4 FY23	Q/Q Change
Revenue	$18.8M	↓ 6.29%
Net Income	$-10.7M	↓ 17.98%
Net Profit Margin	-57.02%	↑ 8.13%

	Q1 FY24	Q/Q Change
Revenue	$19.3M	↑ 2.74%
Net Income	$-16.3M	↑ 52.15%
Net Profit Margin	-84.43%	↓ 27.41%

	Q2 FY24	Q/Q Change
Revenue	$21.4M	↑ 10.93%
Net Income	$-12.3M	↓ 24.2%
Net Profit Margin	-57.69%	↑ 26.74%

	Q3 FY24	Q/Q Change
Revenue	$20.2M	↓ 5.68%
Net Income	$-11.1M	↓ 10.24%
Net Profit Margin	-54.9%	↑ 2.79%

	FY18	Y/Y Change
Profit	$5.2M	-

	FY19	Y/Y Change
Profit	$16.8M	↑ 223.65%

	FY20	Y/Y Change
Profit	$18.4M	↑ 9.68%

	FY21	Y/Y Change
Profit	$40.3M	↑ 118.9%

	FY22	Y/Y Change
Profit	$59.0M	↑ 46.16%

	FY23	Y/Y Change
Profit	$69.2M	↑ 17.31%

	Q2 FY23	Q/Q Change
Profit	$20.1M	↑ 27.35%

	Q3 FY23	Q/Q Change
Profit	$17.3M	↓ 13.73%

	Q4 FY23	Q/Q Change
Profit	$16.0M	↓ 7.83%

	Q1 FY24	Q/Q Change
Profit	$16.5M	↑ 3.11%

	Q2 FY24	Q/Q Change
Profit	$18.3M	↑ 11.37%

	Q3 FY24	Q/Q Change
Profit	$16.9M	↓ 7.84%

	FY18	Y/Y Change
Operating Cash Flow	$-14.5M	-
Investing Cash Flow	$-570.0K	-
Financing Cash Flow	$12.2M	-

	FY19	Y/Y Change
Operating Cash Flow	$-25.0M	↑ 72.69%
Investing Cash Flow	$-672.0K	↑ 17.89%
Financing Cash Flow	$42.7M	↑ 249.62%

	FY20	Y/Y Change
Operating Cash Flow	$-32.2M	↑ 28.71%
Investing Cash Flow	$-953.0K	↑ 41.82%
Financing Cash Flow	$73.4M	↑ 72.04%

	FY21	Y/Y Change
Operating Cash Flow	$-52.5M	↑ 63.3%
Investing Cash Flow	$-813.0K	↓ 14.69%
Financing Cash Flow	$252.5M	↑ 244.04%

	FY22	Y/Y Change
Operating Cash Flow	$-76.0M	↑ 44.59%
Investing Cash Flow	$-970.0K	↑ 19.31%
Financing Cash Flow	$1.2M	↓ 99.51%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-13.5M	↓ 22.4%
Investing Cash Flow	$-97.0K	↓ 23.02%
Financing Cash Flow	$766.0K	↓ 591.03%

Sight Sciences Technicals Summary

Sell

Neutral

Buy

Sight Sciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Sight Sciences (SGHT) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sight Sciences Inc	-19.71%	-50.45%	-37.53%	-82.18%	-91.85%
Medtronic Plc	13.39%	11.64%	3.18%	-11.24%	-23.89%
Edwards Lifesciences Corp.	-2.94%	16.88%	-19.12%	-35.77%	-7.86%
Boston Scientific Corp.	12.9%	39.7%	59.08%	140.2%	144.3%
Stryker Corporation	8.24%	22.38%	15.12%	57.6%	82.09%
Abbott Laboratories	13.63%	16.84%	12.68%	0.31%	46.18%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sight Sciences Inc	NA	NA	NA	-0.86	-0.45	-0.19	NA	1.88
Medtronic Plc	27.77	27.77	1.55	5.45	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	27.56	27.56	6.65	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	84.6	84.6	1.86	2.46	0.09	0.05	NA	14.05
Stryker Corporation	50.49	50.49	2.73	13.51	0.19	0.07	0.01	52.86
Abbott Laboratories	16.74	16.74	2.3	5.15	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sight Sciences Inc	Buy	$141.1M	-91.85%	NA	-63.3%
Medtronic Plc	Buy	$116.5B	-23.89%	27.77	12.06%
Edwards Lifesciences Corp.	Buy	$42.1B	-7.86%	27.56	65.86%
Boston Scientific Corp.	Buy	$150.9B	144.3%	84.6	11.26%
Stryker Corporation	Buy	$149.2B	82.09%	50.49	16.34%
Abbott Laboratories	Buy	$221.9B	46.18%	16.74	13.99%

About Sight Sciences

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

Organization	Sight Sciences
Employees	214
CEO	Mr. Paul Badawi
Industry	Healthcare

Management People of Sight Sciences

Name	Title
Mr. Paul Badawi	Co-Founder, President, CEO & Director
Dr. David Badawi M.D.	Founder, CTO & Director
Ms. Alison Perry Bauerlein	CFO & Treasurer
Mr. Matthew W. Link	Chief Commercial Officer
Mr. Brenton Taylor	Executive Vice President of Operations
Mr. Jeremy B. Hayden J.D.	Chief Legal Officer
Mr. Steve R. Tamayo Jr.	VP and Chief Ethics & Compliance Officer
Dr. Reay H. Brown M.D.	Chief Medical Officer
Dr. Manohar Raheja Ph.D.	Executive Vice President of Research & Development
Mr. Stephen B. Thau J.D.	Secretary

Important FAQs about investing in SGHT Stock from India :

What is Sight Sciences share price today?

Sight Sciences share price today stands at $2.82, Open: $2.73 ; Previous Close: $2.73 ; High: $2.83 ; Low: $2.71 ; 52 Week High: $8.45 ; 52 Week Low: $2.68.

The stock opens at $2.73, after a previous close of $2.73. The stock reached a daily high of $2.83 and a low of $2.71, with a 52-week high of $8.45 and a 52-week low of $2.68.

Can Indians buy Sight Sciences shares?

Yes, Indians can invest in the Sight Sciences (SGHT) from India.

With INDmoney, you can buy Sight Sciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Sight Sciences at zero transaction cost.

How can I buy Sight Sciences shares from India?

It is very easy to buy Sight Sciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sight Sciences (SGHT) be purchased?

Yes, you can buy fractional shares of Sight Sciences with INDmoney app.

What are the documents required to start investing in Sight Sciences stocks?

To start investing in Sight Sciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.